DARE: Dare Bioscience Inc

DARE新闻

• 21:05 12 Health Care Stocks Moving In Monday's After-Market Session
• 21:05 周一盘后交易时段中波动的12只医疗保健股票
• 13:21 Daré Bioscience To Present Clinical Data From A Phase 1 Study Evaluating Sildenafil Cream, 3.6% Investigational Product At The Sexual Medicine Society Of North America Meeting, October 8-11
• 20:05 Daré Bioscience 表示已收到纳斯达克最低买入价不足通知，须在 2027 年 3 月 29 日前恢复合规
• 20:05 Daré Bioscience Says It Received Nasdaq Minimum Bid Price Deficiency Notice, Has Until March 29, 2027 To Regain Compliance
• 12:21 Daré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies
• 23:49 Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour Transcript
• 21:15 Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Beats Revenue Estimates
• 12:25 Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates
• 20:57 Daré Bioscience, Inc. (DARE) Discusses Portfolio Advancements and Therapeutic Solutions for Women's Health Transcript
• 21:50 Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour Transcript
• 05:01 Daré Bioscience, Inc. (DARE) Presents at BIO International Convention 2026 - Slideshow (NASDAQ:DARE) 2026-06-23